Treatment of the cytokine storm in COVID-19: review of clinical pharmacology
AN Sapriati, F Rahmawati… - JSFK (Jurnal Sains …, 2023 - jsfk.ffarmasi.unand.ac.id
The cause of the COVID-19 pandemic can be attributed to the Acute Respiratory Syndrome
Virus-2 (SARS-CoV-2). COVID-19 manifests with severe symptoms in the upper respiratory …
Virus-2 (SARS-CoV-2). COVID-19 manifests with severe symptoms in the upper respiratory …
Treatment outcomes of tocilizumab in critically-ill COVID-19 patients, single-centre retrospective study
W Hafez, MA Ziade, A Arya, H Saleh, M Abdelshakor… - Antibiotics, 2022 - mdpi.com
(1) Background: Severe COVID-19 outcomes are associated with cytokine release
syndrome, characterized by the release of several immune modulators, including Interleukin …
syndrome, characterized by the release of several immune modulators, including Interleukin …
Home-Nebulized Inhaled Glucocorticoid Therapy in Pediatric Respiratory Diseases
J Dong, L Zhang, X Jiang - Journal of Clinical and Nursing …, 2024 - ojs.bbwpublisher.com
Objective: To evaluate the therapeutic effect of home-nebulized inhaled glucocorticoid
therapy in pediatric respiratory diseases. Methods: 60 cases of children with respiratory …
therapy in pediatric respiratory diseases. Methods: 60 cases of children with respiratory …
Protivirová ochrana s využitím složek zázvoru a brukvovité zeleniny.
L Novotný, J Tríska, P Novotná… - Vyziva a Potraviny, 2022 - search.ebscohost.com
Hlavní složky zázvoru, kterými jsou 6-gingerol a 6-shogaol, mají prokazatelné účinky pro
zlepšování funkce imunitního systému člověka a vykazují protivirovou aktivitu proti viru …
zlepšování funkce imunitního systému člověka a vykazují protivirovou aktivitu proti viru …